UK markets closed

XTL Biopharmaceuticals Ltd. (XTLB)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.6500-0.0200 (-0.75%)
As of 01:58PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-1,782
-1,782
-1,348
435
-2,954
Depreciation & amortisation
0
0
1
1
1
Stock-based compensation
3
3
14
37
51
Change in working capital
64
64
-19
-54
45
Accounts payable
19
19
-44
-23
22
Other working capital
-707
-707
-901
-1,049
-851
Other non-cash items
-41
-41
-36
-8
-33
Net cash provided by operating activities
-707
-707
-901
-1,049
-850
Cash flows from investing activities
Investments in property, plant and equipment
-
-
-
-
-1
Purchases of investments
-
-
-
-
0
Sales/maturities of investments
-
-
-
0
0
Net cash used for investing activities
41
41
36
8
32
Cash flows from financing activities
Net cash used provided by (used for) financing activities
0
0
0
385
0
Net change in cash
-666
-666
-865
-656
-818
Cash at beginning of period
2,094
2,094
2,969
3,631
4,455
Cash at end of period
1,401
1,401
2,094
2,969
3,631
Free cash flow
Operating cash flow
-707
-707
-901
-1,049
-850
Capital expenditure
-
-
-
-
-1
Free cash flow
-707
-707
-901
-1,049
-851